Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 521078079 series 9882
Content provided by Sharon Quimby and American Academy of Neurology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sharon Quimby and American Academy of Neurology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Dr. Gregg Day talks with Professor Jonathan Rohrern about the significance of studying individuals at risk of developing genetic frontotemporal dementia, focusing on how early cognitive changes before symptoms appear can inform research and future therapeutic trials.
Read the related article in Neurology®Genetics.
Disclosures can be found at Neurology.org.
1371 episodes
))
